Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8264 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8175 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7987 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7923 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7786 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7698 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7652 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7615 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7597 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7597 |
Intermediate Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD8360 |
Approved |
0.756 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7545 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7467 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7463 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7445 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7379 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7287 |
Intermediate Similarity |
NPD164 |
Approved |
0.7285 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD37 |
Approved |
0.72 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7305 |
Phase 1 |
0.7176 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7109 |
Intermediate Similarity |
NPD1238 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD5048 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6287 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7077 |
Intermediate Similarity |
NPD1929 |
Approved |
0.7077 |
Intermediate Similarity |
NPD1930 |
Approved |
0.7077 |
Intermediate Similarity |
NPD6647 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7071 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7069 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7059 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7042 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7041 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7039 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.7023 |
Intermediate Similarity |
NPD1237 |
Approved |
0.7023 |
Intermediate Similarity |
NPD5909 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD2067 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1934 |
Approved |
0.6994 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6985 |
Remote Similarity |
NPD6858 |
Approved |
0.6985 |
Remote Similarity |
NPD7094 |
Approved |
0.6982 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6975 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6974 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD5740 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD6085 |
Phase 2 |
0.6963 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD5494 |
Approved |
0.6948 |
Remote Similarity |
NPD3750 |
Approved |
0.6937 |
Remote Similarity |
NPD6386 |
Approved |
0.6937 |
Remote Similarity |
NPD6385 |
Approved |
0.6934 |
Remote Similarity |
NPD6010 |
Discontinued |
0.6933 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6799 |
Approved |
0.6914 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD5402 |
Approved |
0.6908 |
Remote Similarity |
NPD5404 |
Approved |
0.6908 |
Remote Similarity |
NPD5405 |
Approved |
0.6908 |
Remote Similarity |
NPD5406 |
Approved |
0.6908 |
Remote Similarity |
NPD5408 |
Approved |
0.6905 |
Remote Similarity |
NPD7228 |
Approved |
0.6905 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6903 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD1470 |
Approved |
0.6892 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6887 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6886 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD6784 |
Approved |
0.6879 |
Remote Similarity |
NPD6785 |
Approved |
0.6879 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6863 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6863 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6857 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6853 |
Remote Similarity |
NPD4806 |
Approved |
0.6853 |
Remote Similarity |
NPD4807 |
Approved |
0.6852 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD2801 |
Approved |
0.6846 |
Remote Similarity |
NPD7714 |
Approved |
0.6846 |
Remote Similarity |
NPD2066 |
Phase 3 |
0.6846 |
Remote Similarity |
NPD7715 |
Approved |
0.6842 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6839 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6831 |
Remote Similarity |
NPD5306 |
Approved |
0.6831 |
Remote Similarity |
NPD17 |
Approved |
0.6831 |
Remote Similarity |
NPD5305 |
Approved |
0.6824 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6824 |
Remote Similarity |
NPD7095 |
Approved |
0.6821 |
Remote Similarity |
NPD3528 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6807 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6806 |
Remote Similarity |
NPD3972 |
Approved |
0.6805 |
Remote Similarity |
NPD7177 |
Discontinued |
0.68 |
Remote Similarity |
NPD4140 |
Approved |
0.6797 |
Remote Similarity |
NPD6100 |
Approved |
0.6797 |
Remote Similarity |
NPD6099 |
Approved |
0.6797 |
Remote Similarity |
NPD2796 |
Approved |
0.6792 |
Remote Similarity |
NPD5403 |
Approved |
0.6791 |
Remote Similarity |
NPD6685 |
Approved |
0.6788 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD2797 |
Approved |
0.6779 |
Remote Similarity |
NPD3268 |
Approved |
0.6776 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6772 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6769 |
Remote Similarity |
NPD9495 |
Approved |
0.6768 |
Remote Similarity |
NPD3882 |
Suspended |
0.6766 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6765 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD7054 |
Approved |
0.6761 |
Remote Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.6755 |
Remote Similarity |
NPD447 |
Suspended |
0.6753 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD5763 |
Approved |
0.6753 |
Remote Similarity |
NPD5762 |
Approved |
0.6739 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6739 |
Remote Similarity |
NPD8319 |
Approved |
0.6736 |
Remote Similarity |
NPD1201 |
Approved |
0.6735 |
Remote Similarity |
NPD2798 |
Approved |
0.6733
|
Remote Similarity |
NPD7713 |
Phase 3 |